Abstract
Inhibition of cholinesterases is the key by which organophosphates (OP) exert their toxic effects on the target organism. Humans are affected by OP poisoning by both acute (intentional and unintentional) and chronic toxicity. Phosphorylation of AChE at serine residue in the catalytic gorge is leading to the formation of AChE-OP adduct. Reactivation of AChE by self is nearly impossible. Oximes are potent reactivators of AChE. Bioscavenging the OP available in the bloodstream is an alternate way of protecting endogenous cholinesterases. This chapter has discussed the management of AChE by means of reactivation, bioscavenging using stoichiometric and catalytic bioscavengers, and nanotechnological approaches. The possibility of reactivation of aged AChE has also been discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ashani, Y., Grauer, E., Grunwald, J., Allon, N., & Raveh, L. (1998). Current capabilities in extrapolating from animal to human the capacity of human butyrylcholinesterase to detoxify organophosphates. In Structure and function of cholinesterases and related proteins (pp. 255–260). Springer.
Ashani, Y., Leader, H., Aggarwal, N., Silman, I., Worek, F., Sussman, J. L., & Goldsmith, M. (2016). In vitro evaluation of the catalytic activity of paraoxonases and phosphotriesterases predicts the enzyme circulatory levels required for in vivo protection against organophosphate intoxications. Chemico-Biological Interactions, 259, 252–256.
Aurbek, N., Thiermann, H., Szinicz, L., Eyer, P., & Worek, F. (2006). Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase. Toxicology, 224(1–2), 91–99.
Bigley, A. N., Mabanglo, M. F., Harvey, S. P., & Raushel, F. M. (2015). Variants of phosphotriesterase for the enhanced detoxification of the chemical warfare agent VR. Biochemistry, 54(35), 5502–5512.
Blanton, T. (2015). Quinone methide precursors as potential therapeutics towards the Realkylation of aged acetylcholinesterase. The Ohio State University.
Bourne, Y., Taylor, P., Radić, Z., & Marchot, P. (2003). Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. The EMBO Journal, 22(1), 1–12.
Brazzolotto, X., Wandhammer, M., Ronco, C., Trovaslet, M., Jean, L., Lockridge, O., Renard, P., & Nachon, F. (2012). Human butyrylcholinesterase produced in insect cells: Huprine-based affinity purification and crystal structure. The FEBS Journal, 279(16), 2905–2916.
Bunton, C. A., & Ihara, Y. (1977). Micellar effects upon dephosphorylation and deacylation by oximate ions. The Journal of Organic Chemistry, 42(17), 2865–2869.
Cerasoli, D. M., Armstrong, S. J., Reeves, T. E., Hodgins, S. M., Kasten, S. A., Lee-Stubbs, R. B., Cadieux, C. L., Otto, T. C., Capacio, B. R., & Lenz, D. E. (2020). Butyrylcholinesterase, a stereospecific in vivo bioscavenger against nerve agent intoxication. Biochemical Pharmacology, 171, 113670.
COHEN, O., KRONMAN, C., CHITLARU, T., ORDENTLICH, A., VELAN, B., & SHAFFERMAN, A. (2001). Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity. Biochemical Journal, 357(3), 795–802.
Cohen, O., Kronman, C., Raveh, L., Mazor, O., Ordentlich, A., & Shafferman, A. (2006). Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds. Molecular Pharmacology, 70(3), 1121–1131.
De Koning, M. C., Joosen, M. J. A., Noort, D., Van Zuylen, A., & Tromp, M. C. (2011). Peripheral site ligand–oxime conjugates: A novel concept towards reactivation of nerve agent-inhibited human acetylcholinesterase. Bioorganic & Medicinal Chemistry, 19(1), 588–594.
Delfino, R. T., Ribeiro, T. S., & Figueroa-Villar, J. D. (2009). Organophosphorus compounds as chemical warfare agents: A review. Journal of the Brazilian Chemical Society, 20(3), 407–428.
DeMar, J. C., Clarkson, E. D., Ratcliffe, R. H., Campbell, A. J., Thangavelu, S. G., Herdman, C. A., Leader, H., Schulz, S. M., Marek, E., & Medynets, M. A. (2010). Pro-2-PAM therapy for central and peripheral cholinesterases. Chemico-Biological Interactions, 187(1–3), 191–198.
Eyer, P., & Buckley, N. (2006). Pralidoxime for organophosphate poisoning. Lancet, 368(9553), 2110.
Fabry, S. (2016). Synthesis of Fluorobenzyl Alkylators: Studies toward Realkylation of aged acetylcholinesterase. The Ohio State University.
Franjesevic, A. J., Sillart, S. B., Beck, J. M., Vyas, S., Callam, C. S., & Hadad, C. M. (2019). Resurrection and reactivation of acetylcholinesterase and butyrylcholinesterase. Chemistry (Weinheim an Der Bergstrasse, Germany), 25(21), 5337.
Goldsmith, M., Aggarwal, N., Ashani, Y., Jubran, H., Greisen, P. J., Ovchinnikov, S., Leader, H., Baker, D., Sussman, J. L., & Goldenzweig, A. (2017). Overcoming an optimization plateau in the directed evolution of highly efficient nerve agent bioscavengers. Protein Engineering, Design and Selection, 30(4), 333–345.
Goldsmith, M., Eckstein, S., Ashani, Y., Greisen, P., Leader, H., Sussman, J. L., Aggarwal, N., Ovchinnikov, S., Tawfik, D. S., & Baker, D. (2016). Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro. Archives of Toxicology, 90(11), 2711–2724.
Haque, M. A., Lee, H. Y., Cho, D. Y., Lee, J. H., Hwang, C. E., & Cho, K. M. (2020). Cloning, expression, and functional characterization of an organophosphates insecticides degrading gene (opdC) from a potential probiotic Lactobacillus plantarum WCP931.
Hiblot, J., Bzdrenga, J., Champion, C., Chabriere, E., & Elias, M. (2015). Crystal structure of Vmo lac, a tentative quorum quenching lactonase from the extremophilic crenarchaeon Vulcanisaeta moutnovskia. Scientific Reports, 5(1), 1–11.
Hrvat, N. M., Zorbaz, T., Šinko, G., & Kovarik, Z. (2018). The estimation of oxime efficiency is affected by the experimental design of phosphylated acetylcholinesterase reactivation. Toxicology Letters, 293, 222–228.
Jacquet, P., Daudé, D., Bzdrenga, J., Masson, P., Elias, M., & Chabrière, E. (2016). Current and emerging strategies for organophosphate decontamination: Special focus on hyperstable enzymes. Environmental Science and Pollution Research, 23(9), 8200–8218.
Katz, F. S., Pecic, S., Schneider, L., Zhu, Z., Hastings, A., Luzac, M., Macdonald, J., Landry, D. W., & Stojanovic, M. N. (2018). New therapeutic approaches and novel alternatives for organophosphate toxicity. Toxicology Letters, 291, 1–10.
Kharel, H., Pokhrel, N. B., Ghimire, R., & Kharel, Z. (2020). The efficacy of pralidoxime in the treatment of organophosphate poisoning in humans: A systematic review and meta-analysis of randomized trials. Cureus, 12(3).
Kronman, C., Velan, B., Marcus, D., Ordentlich, A., Reuveny, S., & Shafferman, A. (1995). Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation. Biochemical Journal, 311(3), 959–967.
Kuca, K., Jun, D., & Musilek, K. (2006). Structural requirements of acetylcholinesterase reactivators. Mini Reviews in Medicinal Chemistry, 6(3), 269–277.
Kusic, R., Jovanovic, D., Randjelovic, S., Joksovic, D., Todorovic, V., Boskovic, B., Jokanovic, M., & Vojvodic, V. (1991). HI-6 in man: Efficacy of the oxime in poisoning by organophosphorus insecticides. Human & Experimental Toxicology, 10(2), 113–118.
Luo, C., Saxena, A., Smith, M., Garcia, G., Radić, Z., Taylor, P., & Doctor, B. P. (1999). Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium. Biochemistry, 38(31), 9937–9947.
Main, A. R. (1979). Mode of action of anticholinesterases. Pharmacology & Therapeutics, 6(3), 579–628.
Modica, E., Zanaletti, R., Freccero, M., & Mella, M. (2001). Alkylation of amino acids and glutathione in water by o-quinone methide. Reactivity and selectivity. The Journal of Organic Chemistry, 66(1), 41–52.
Mumford, H., Docx, C. J., Price, M. E., Green, A. C., Tattersall, J. E. H., & Armstrong, S. J. (2013). Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning. Chemico-Biological Interactions, 203(1), 160–166.
Nachon, F., Brazzolotto, X., Trovaslet, M., & Masson, P. (2013). Progress in the development of enzyme-based nerve agent bioscavengers. Chemico-Biological Interactions, 206(3), 536–544.
Ordentlich, A., Barak, D., Kronman, C., Benschop, H. P., De Jong, L. P. A., Ariel, N., Barak, R., Segall, Y., Velan, B., & Shafferman, A. (1999). Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers. Biochemistry, 38(10), 3055–3066.
Pang, Z., Hu, C.-M. J., Fang, R. H., Luk, B. T., Gao, W., Wang, F., Chuluun, E., Angsantikul, P., Thamphiwatana, S., Lu, W., Jiang, X., & Zhang, L. (2015). Detoxification of organophosphate poisoning using nanoparticle bioscavengers. ACS Nano, 9(6), 6450–6458. https://doi.org/10.1021/acsnano.5b02132
Pashirova, T. N., Braïki, A., Zueva, I. V., Petrov, K. A., Babaev, V. M., Burilova, E. A., Samarkina, D. A., Rizvanov, I. K., Souto, E. B., & Jean, L. (2018). Combination delivery of two oxime-loaded lipid nanoparticles: Time-dependent additive action for prolonged rat brain protection. Journal of Controlled Release, 290, 102–111.
Pashirova, T. N., Zueva, I. V., Petrov, K. A., Lukashenko, S. S., Nizameev, I. R., Kulik, N. V., Voloshina, A. D., Almasy, L., Kadirov, M. K., & Masson, P. (2018). Mixed cationic liposomes for brain delivery of drugs by the intranasal route: The acetylcholinesterase reactivator 2-PAM as encapsulated drug model. Colloids and Surfaces B: Biointerfaces, 171, 358–367.
Radić, Z., Sit, R. K., Garcia, E., Zhang, L., Berend, S., Kovarik, Z., Amitai, G., Fokin, V. V, Sharpless, K. B., & Taylor, P. (2013). Mechanism of interaction of novel uncharged, centrally active reactivators with OP-hAChE conjugates. Chemico-Biological Interactions, 203(1), 67–71.
Raveh, L., Grauer, E., Grunwald, J., Cohen, E., & Ashani, Y. (1997). The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Toxicology and Applied Pharmacology, 145(1), 43–53.
Raveh, L., Grunwald, J., Marcus, D., Papier, Y., Cohen, E., & Ashani, Y. (1993). Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity: In vitro and in vivo quantitative characterization. Biochemical Pharmacology, 45(12), 2465–2474.
Restaino, O. F., Borzacchiello, M. G., Scognamiglio, I., Porzio, E., Manco, G., Fedele, L., Donatiello, C., De Rosa, M., & Schiraldi, C. (2017). Boosted large-scale production and purification of a thermostable archaeal phosphotriesterase-like lactonase for organophosphate decontamination. Journal of Industrial Microbiology and Biotechnology, 44(3), 363–375.
Rochu, D., Chabriere, E., & Masson, P. (2007). Human paraoxonase: A promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology, 233(1–3), 47–59.
Rosenberg, Y. J., Saxena, A., Sun, W., Jiang, X., Chilukuri, N., Luo, C., Doctor, B. P., & Lee, K. D. (2010). Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycol-conjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model. Chemico-Biological Interactions, 187(1–3), 279–286.
Rosenstock, L., Keifer, M., Daniell, W. E., McConnell, R., Claypoole, K., & Group, P. H. E. S. (1991). Chronic central nervous system effects of acute organophosphate pesticide intoxication. The Lancet, 338(8761), 223–227.
Saxena, A., Sun, W., Luo, C., Myers, T. M., Koplovitz, I., Lenz, D. E., & Doctor, B. P. (2006). Bioscavenger for protection from toxicity of organosphosphorus compounds. Journal of Molecular Neuroscience, 30(1–2), 145–147.
Smith, P. N., Mao, L., Sinha, K., & Russell, A. J. (2021). Organophosphate detoxification by membrane-engineered red blood cells. Acta Biomaterialia, 124, 270–281.
Wille, T., Neumaier, K., Koller, M., Ehinger, C., Aggarwal, N., Ashani, Y., Goldsmith, M., Sussman, J. L., Tawfik, D. S., & Thiermann, H. (2016). Single treatment of VX poisoned Guinea pigs with the phosphotriesterase mutant C23AL: Intraosseous versus intravenous injection. Toxicology Letters, 258, 198–206.
Wong, L., Radić, Z., Brüggemann, R. J. M., Hosea, N., Berman, H. A., & Taylor, P. (2000). Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis. Biochemistry, 39(19), 5750–5757.
Worek, F., & Thiermann, H. (2013). The value of novel oximes for treatment of poisoning by organophosphorus compounds. Pharmacology & Therapeutics, 139(2), 249–259.
Worek, F., Thiermann, H., & Wille, T. (2016). Oximes in organophosphate poisoning: 60 years of hope and despair. Chemico-Biological Interactions, 259, 93–98.
Yoder, R. J., Zhuang, Q., Beck, J. M., Franjesevic, A., Blanton, T. G., Sillart, S., Secor, T., Guerra, L., Brown, J. D., & Reid, C. (2017). Study of Para-Quinone Methide precursors toward the Realkylation of aged acetylcholinesterase. ACS Medicinal Chemistry Letters, 8(6), 622–627.
Zueva, I. V., Lushchekina, S. V., & Masson, P. (2018). Water structure changes in oxime-mediated reactivation process of phosphorylated human acetylcholinesterase. Bioscience Reports, 38(3), BSR20180609.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ranjan, A., **dal, T. (2022). Management and Modulation of Cholinesterase. In: Toxicology of Organophosphate Poisoning. Springer, Cham. https://doi.org/10.1007/978-3-030-79128-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-79128-5_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-79127-8
Online ISBN: 978-3-030-79128-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)